A detailed history of N Verses Capital, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 3,300 shares of CDNA stock, worth $78,804. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,300
Previous 1,200 175.0%
Holding current value
$78,804
Previous $18.6 Million 452.92%
% of portfolio
0.05%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$14.41 - $33.99 $30,261 - $71,379
2,100 Added 175.0%
3,300 $103 Million
Q2 2024

Jul 31, 2024

BUY
$7.56 - $16.15 $9,072 - $19,380
1,200 New
1,200 $18.6 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.28B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.